HIV Citation List: November 25, 2011 - December 8, 2011
Pubmed citations
1. Biochemistry and Biophysics of HIV-1 gp41 - Membrane Interactions and Implications for HIV-1 Envelope Protein Mediated Viral-Cell Fusion and Fusion Inhibitor Design. Cai, L., M. Gochin, and K. Liu, Current Topics in Medicinal Chemistry, 2011. 11(24): p. 2959-2984; PMID[22044229].
[Pubmed]. HIV_1125-120811.
2. The Crystal Structure of Protease Sapp1p from Candida parapsilosis in Complex with the HIV protease Inhibitor Ritonavir. Dostal, J., J. Brynda, O. Hruskova-Heidingsfeldova, P. Pachl, I. Pichova, and P. Rezacova, Journal of Enzyme Inhibition and Medicinal Chemistry 2011. [Epub ahead of print]; PMID[22146051].
[Pubmed]. HIV_1125-120811.
3. Design, Synthesis and Biological Evaluation of cycloalkyl arylpyrimidines (CAPYs) as HIV-1 NNRTIs. Gu, S.X., S.Q. Yang, Q.Q. He, X.D. Ma, F.E. Chen, H.F. Dai, E.D. Clercq, J. Balzarini, and C. Pannecouque, Bioorganic & Medicinal Chemistry, 2011. 19(23): p. 7093-7099; PMID[22037050].
[Pubmed]. HIV_1125-120811.
4. Antiviral Interactions of Combinations of Highly Potent 2,4(1H,3H)-Pyrimidinedione Congeners and other anti-HIV Agents. Hartman, T.L., L. Yang, and R.W. Buckheit, Jr., Antiviral Research 2011. 92(3): p. 505-508; PMID[22036651].
[Pubmed]. HIV_1125-120811.
5. Initial viral decay to assess the relative antiretroviral potency of protease inhibitor-sparing, nonnucleoside reverse transcriptase inhibitor-sparing, and nucleoside reverse transcriptase inhibitor-sparing regimens for first-line therapy of HIV infection. Haubrich, R.H., S.A. Riddler, H. Ribaudo, G. Direnzo, K.L. Klingman, K.W. Garren, D.L. Butcher, J.F. Rooney, D.V. Havlir, and J.W. Mellors, AIDS, 2011. 25(18): p. 2269-2278; PMID[21941167].
[Pubmed]. HIV_1125-120811.
6. The molecular pharmacology of AMD11070: An orally bioavailable CXCR4 HIV entry inhibitor. Mosi, R.M., V. Anastassova, J. Cox, M.C. Darkes, S.R. Idzan, J. Labrecque, G. Lau, K.L. Nelson, K. Patel, Z. Santucci, R.S. Wong, R.T. Skerlj, G.J. Bridger, D. Huskens, D. Schols, and S.P. Fricker, Biochemical Pharmacology, 2011. [Epub ahead of print]; PMID[22146583].
[Pubmed]. HIV_1125-120811.
7. Structure-Based Design of a Protein Immunogen that Displays an HIV-1 gp41 Neutralizing Epitope. Stanfield, R.L., J.P. Julien, R. Pejchal, J.S. Gach, M.B. Zwick, and I.A. Wilson, Journal of Molecular Biology, 2011. 414(3): p. 460-476; PMID[22033480].
[Pubmed]. HIV_1125-120811.
8. Bifunctional Cinchona Alkaloid Thiourea Catalyzed Highly Efficient, Enantioselective Aza-Henry Reaction of Cyclic Trifluoromethyl Ketimines: Synthesis of Anti-HIV Drug DPC 083. Xie, H., Y. Zhang, S. Zhang, X. Chen, and W. Wang, Angewandte Chemie, 2011. 50(49): p. 11773-11776; PMID[21989976]. [Pubmed]. HIV_1125-120811.
ISI Web of Knowledge citations
9. Synthesis and anti-HIV Activity of New Benzimidazole, Benzothiazole and Carbohyrazide Derivatives of the anti-Inflammatory Drug Indomethacin. Al-Masoudi, N.A., N.N.A. Jafar, L.J. Abbas, S.J. Baqir, and C. Pannecouque, Zeitschrift Fur Naturforschung Section B-a Journal of Chemical Sciences, 2011. 66(9): p. 953-960; ISI[000296938000014].
[WOS]. HIV_1125-120811.
10. Chemically modified tetracycline-3 (CMT-3): A novel inhibitor of the serine proteinase, elastase. Gu, Y., H.M. Lee, S.R. Simon, and L.M. Golub, Pharmacological Research, 2011. 64(6): p. 595-601; ISI[000296756000008].
[WOS]. HIV_1125-120811.
11. Picomolar Dichotomous Activity of Gnidimacrin Against HIV-1.Huang, L.H., P Yu, J Zhu, L Lee, KH Chen, CH, Plos One, 2011. 6(10); ISI[000296515200040].
[WOS]. HIV_1125-120811.
12. QSAR modeling of the inhibition of reverse transcriptase enzyme with benzimidazolone analogs. Kumar, S., V. Singh, and M. Tiwari, Medicinal Chemistry Research, 2011. 20(9): p. 1530-1541; ISI[000296477900017].
[WOS]. HIV_1125-120811.
13. Quantitative structure activity relationship (QSAR) studies of a series of 2,5-disubstituted-1,3,4-oxadiazole derivatives as biologically potential compounds. Pal, T., R.R. Somani, P.Y. Shirodkar, and U.V. Bhanushali, Medicinal Chemistry Research, 2011. 20(9): p. 1550-1555; ISI[000296477900019].
[WOS]. HIV_1125-120811.
14. Synthesis and antiviral activity of 2 '-deoxy-2 '-fluoro-2 '-C-methyl-7-deazapurine nucleosides, their phosphoramidate prodrugs and 5 '-triphosphates. Shi, J.X., L.H. Zhou, H.W. Zhang, T.R. McBrayer, M.A. Detorio, M. Johns, L. Bassit, M.H. Powdrill, T. Whitaker, S.J. Coats, M. Gotte, and R.F. Schinazi, Bioorganic & Medicinal Chemistry Letters, 2011. 21(23): p. 7094-7098; ISI[000296717600034] [WOS]. HIV_1125-120811.
15. Modeling of novel HIV-1 protease inhibitors incorporating N-Aryl-oxazolidinone-5-carboxamides as P2 ligands using quantum chemical and topological finger print descriptors. Singh, S.S., S Shukla, P, Medicinal Chemistry Research, 2011. 20(9): p. 1556-1565; ISI[000296477900020].
[WOS]. HIV_1125-120811.
Patent Citations
16. Preparation of Benzenesulfonamide Derivatives as anti-HIV Agents. Chen, F., S. Gu, X. Ma, Q. He, Y. Zheng, X. Zhang, and L. Yang. Patent. 2011-10099552 102229547, 11pp.
[Patent]. HIV_1125-120811.
17. Preparation of Carboxamide Derivatives Useful in the Treatment of AIDS and Cancer. Chen, F., X. Ma, S. Gu, Q. He, Y. Zheng, X. Zhang, and L. Yang. Patent. 2011-10099575 102219717, 12pp.
[Patent]. HIV_1125-120811.
18. Small-Molecule Modulators of HIV-1 Capsid Stability and Methods Thereof. Cocklin, S., S. Kortagere, and A.B. Smith, III. Patent. 2011-US33789 2011139637, 121pp.
[Patent]. HIV_1125-120811.
19. Reducing Transmission of Sexually Transmitted Infections Using a Semen-derived Enhancer of Viral Infection (Sevi)-Binding Agent. Dewhurst, S., B. Nilsson, J. Olsen, and J. Yang. Patent. 2011-US33659 2011133929, 74pp.
[Patent]. HIV_1125-120811.
20. Characterization of Bifunctional Polypeptides for Inactivating HIV and Blocking HIV Entry. Jiang, S., C. Pan, and L. Lu. Patent. 2011-100031
20110269676, 55pp.
[Patent]. HIV_1125-120811.
21. Bifunctional Griffithsin Analogs Comprising gp120-binding Proteins and gp41-binding Proteins, for use in Prevention of HIV Infection. Liwang, P.J. and I. Kagiampakis. Patent. 2010-957261 20110263485, 44pp.
[Patent]. HIV_1125-120811.
22. Preparation of Menthyl 2',3'-didehydro-3'-deoxythymidine 5'-hydrogenphosphonate for Treating AIDS. Wu, Z., S. Du, M. Ao, Z. Cai, and Y. Zhao. Patent. 2011-10085220 102212083, 7pp.
[Patent]. HIV_1125-120811.
23. Indole, Azaindole and Related Heterocyclic N-Substituted piperazine Derivatives and Their Preparation and use for the Treatment of HIV Infection. Yeung, K.-S., M.E. Farkas, J.F. Kadow, N.A. Meanwell, M. Taylor, D. Johnston, T.S. Coulter, and J.J.K. Wright. Patent. 2008-28189
8039486, 118pp , Cont -in-part of U S Ser No 129,673.
[Patent]. HIV_1125-120811.
24. Preparation of Betulin Derivatives for Treatment of HIV-1. Gao, D., N. Han, Z. Jin, F. Ning, J. Tang, Y. Wu, and H. Yang. Patent. 2011-US24174 2011100308, 52pp.
[Patent]. HIV_1125-120811.
25. Preparation of Styrylquinolines and Their Therapeutic uses as Integrase Inhibitors and for the Treatment and Prevention of HIV. Giethlen, B., M. Michaut, C. Monneret, E. Soma, L. Thibault, and C.G. Wermuth. Patent. 2011-55703 20110224242, 18pp , Cont -in-part of U S Ser No 269,241.
[Patent]. HIV_1125-120811.
26. Ferrocenyl Flavonoids. Hillard, E., G. Chabot, J.-P. Monserrat, G. Jaouen, K.N. Tiwari, F. De Montigny, and N. Neamati. Patent. 2011-EP53249 2011107572, 50pp.
[Patent]. HIV_1125-120811.
27. Preparation of Oxazinonaphthyridine Derivatives for use as anti-HIV Agents. Jin, H., C.U. Kim, and B.W. Phillips,. Patent. 2011-US25948
2011106445, 56pp.
[Patent]. HIV_1125-120811.
28. CXCR4 Receptor Allosteric Modulators. Looby, R.J. and B. Tchernychev. Patent. 2011-US26322 2011106703, 142pp.
[Patent]. HIV_1125-120811.
29. Preparation of 1,3,4,8-Tetrahydro-2h-pyrido[1,2-a]pyrazine Derivatives and Their use as HIV Integrase Inhibitors. Miyazaki, S., Y. Bessho, K. Adachi, S. Kawashita, H. Isoshima, K. Oshita, and S. Fukuda. Patent. 2011-JP54404 2011105590, 278pp.
[Patent]. HIV_1125-120811.
30. 1-Phenyl-1,5-dihydrobenzo[B][1,4]diazepine-2,4-dione Derivatives as HIV Replication Inhibitors and Their Preparation and use for the Treatment of HIV Infection. Simoneau, B., P. Deroy, L. Fader, A.-M. Faucher, A. Gagnon, C. Grand-Maitre, S. Kawai, S. Landry, J.-F. Mercier, and J. Rancourt. Patent. 2011-CA50071 2011100838, 122pp.
[Patent]. HIV_1125-120811.
31. Preparation of 1-[(5-Oxo-4,5-dihydro-1h-1,2,4-triazol-3-yl)methyl]-pyridin-2(1h)-one Compounds as Non-Nucleoside Reverse Transcriptase Inhibitors. Burch, J., B. Cote, N. Nguyen, C.S. Li, M. St-Onge, and D. Gauvreau. Patent. 2011-CA320 2011120133, 83pp.
[Patent]. HIV_1125-120811.
32. 5-Hydroxyquinolinone Derivative, Its Preparation Method and Application in Preparing the Medicine for Treating and Preventing Acquired Immune Deficiency Syndrome (AIDS). Chen, F., Q. He, H. Wu, S. Gu, X. Ma, Y. Zheng, X. Zhang, and L. Yang. Patent. 2011-10099562 102212032, 14pp.
[Patent]. HIV_1125-120811.
33. Preparation of Benzhydrol Derivatives as anti-HIV and Antitumor Agents. Chen, F., X. Ma, S. Gu, Q. He, Y. Zheng, X. Zhang, and L. Yang. Patent. 2011-10099577 102212022, 9pp.
[Patent]. HIV_1125-120811.
34. Preparation of 1-Naphthylbenzophenone Derivatives for use as Antiviral and Anticancer Agents. Chen, F., X. Ma, S. Gu, Q. He, Y. Zheng, X. Zhang, and L. Yang. Patent. 2011-10099574 102206177, 8pp.
[Patent]. HIV_1125-120811.
35. Pyrimidines and Pyridopyridazine Derivatives and Related Compounds as anti-HIV Agents and Their Preparation and Method for Treatment of HIV. Danter, W., C. Threlfall, S. Guizzetti, and J. Marin. Patent. 2011-CA357 2011120153, 149pp.
[Patent]. HIV_1125-120811.
36. Antiviral Compounds and Methods of use Thereof. Guenther, R.H. and J.R. Szewczyk. Patent. 2011-US28397 2011113060, 129pp.
[Patent]. HIV_1125-120811.
37. Pyridone Derivative Having Integrase Inhibitory Activity. Hattori, K. and K. Tomita. Patent. 2011-JP2139 2011129095, 111pp.
[Patent]. HIV_1125-120811.
38. Nucleobase-bound Phosphonates with Reduced Toxicity for Treatment of Viral Infections. Hostetler, K.Y., J.R. Beadle, and N. Valiaeva. Patent. 2011-US32558 2011130557, 84pp.
[Patent]. HIV_1125-120811.
39. Preparation of Heterocycles as HIV Protease Inhibitors. Li, S., Y. Hu, J. Yan, D. Bai, and L. Zhou. Patent. 2010-10125641 102190638, 27pp.
[Patent]. HIV_1125-120811.
40. Preparation of anti-HIV Polypeptides. Liu, K., S. Jiang, Q. Jia, W. Shi, Y. Bai, S. Feng, X. Kang, C. Yang, S. Zhang, and B. Zheng. Patent. 2010-CN488 2011127624, 22pp.
[Patent]. HIV_1125-120811.
41. Banana Lectins and uses Thereof. Markovitz, D., M. Swanson, I. Goldstein, and H. Winter. Patent. 2011-US31895 2011130145, 42pp.
[Patent]. HIV_1125-120811.
42. Preparation of Macrocyclic Pyrazinopyrrolopyridazine dione Derivatives as HIV Replication Inhibitors. Thuring, J.W.J. and J.F. Bonfanti. Patent. 2011-EP55077 2011121105, 123pp.
[Patent]. HIV_1125-120811.
43. 6-Pyridyl Substituted Pyrimidine Derivitives and Their use as Antiviral Agents. Chu, S.H., Y.C. Cheng, B.C. Pan. Patent. 1993-WO9323390, 32pp.
[Patent]. HIV_1125-120811.
44. Synthesis and anti-HIV-1 Activities of 6-Arylthio and 6-Arylselenoacyclonucleosides. Bai-Chuan, P., Z.H. Chen, G. Piras, G.E.Deutschman, E. Rowe, S.H. Chu. Journal of Heterocyclic Chemistry, 1994. 31(1): p. 177-185.
[Patent]. HIV_1125-120811.